Pillar Biosciences Announces Final CMS Pricing Determination for oncoReveal® CDx
Natick, Mass. – December 1, 2025 – Pillar Biosciences, the leader in Decision Medicine™, todayannounced that the Centers for Medicare & Medicaid Services (CMS) has finalized its pricingdetermination for oncoReveal CDx. Following its preliminary decision in August 2025, CMSconfirmed a crosswalk-based payment rate of $1,352.09, effective for claims with dates of service onor after January […]